VE-Albumin Core-Shell Nanoparticles for Paclitaxel Delivery to Treat MDR Breast Cancer
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
VE-Albumin Core-Shell Nanoparticles for Paclitaxel Delivery to Treat MDR Breast Cancer
Authors
Keywords
-
Journal
MOLECULES
Volume 23, Issue 11, Pages 2760
Publisher
MDPI AG
Online
2018-10-26
DOI
10.3390/molecules23112760
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- HSA-based multi-target combination therapy: regulating drugs’ release from HSA and overcoming single drug resistance in a breast cancer model
- (2018) Yi Gou et al. DRUG DELIVERY
- Folic acid conjugated bovine serum albumin: An efficient smart and tumor targeted biomacromolecule for inhibition folate receptor positive cancer cells
- (2018) Hamed Nosrati et al. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES
- Leveraging Engineering of Indocyanine Green-Encapsulated Polymeric Nanocomposites for Biomedical Applications
- (2018) Ya-Hui Han et al. Nanomaterials
- Solution-enhanced dispersion by supercritical fluids: an ecofriendly nanonization approach for processing biomaterials and pharmaceutical compounds
- (2018) Ranjith Kankala et al. International Journal of Nanomedicine
- Overcoming multidrug resistance through inhalable siRNA nanoparticles-decorated porous microparticles based on supercritical fluid technology
- (2018) Pei-Yao Xu et al. International Journal of Nanomedicine
- Vitamin E: Emerging aspects and new directions
- (2017) Francesco Galli et al. FREE RADICAL BIOLOGY AND MEDICINE
- Co-delivery strategies to overcome multidrug resistance in ovarian cancer
- (2017) Ikram Ullah Khan et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Design of an Anticancer Copper(II) Prodrug Based on the Lys199 Residue of the Active Targeting Human Serum Albumin Nanoparticle Carrier
- (2017) Yi Gou et al. MOLECULAR PHARMACEUTICS
- Polyester–Solid Lipid Mixed Nanoparticles with Improved Stability in Gastro-Intestinal Tract Facilitated Oral Delivery of Larotaxel
- (2017) Jingxin Gou et al. MOLECULAR PHARMACEUTICS
- Supercritical Fluid Technology: An Emphasis on Drug Delivery and Related Biomedical Applications
- (2017) Ranjith Kumar Kankala et al. Advanced Healthcare Materials
- Overcoming multidrug resistance through co-delivery of ROS-generating nano-machinery in cancer therapeutics
- (2017) Ranjith Kumar Kankala et al. Journal of Materials Chemistry B
- Overcoming Multidrug Resistance through the Synergistic Effects of Hierarchical pH-Sensitive, ROS-Generating Nanoreactors
- (2017) Ranjith Kumar Kankala et al. ACS Biomaterials-Science & Engineering
- Overcoming Multidrug Resistance through the Synergistic Effects of Hierarchical pH-Sensitive, ROS-Generating Nanoreactors
- (2017) Ranjith Kumar Kankala et al. ACS Biomaterials Science & Engineering
- Liposomal co-delivery of curcumin and albumin/paclitaxel nanoparticle for enhanced synergistic antitumor efficacy
- (2015) Hima Bindu Ruttala et al. COLLOIDS AND SURFACES B-BIOINTERFACES
- pH-responsive hybrid quantum dots for targeting hypoxic tumor siRNA delivery
- (2015) HongYan Zhu et al. JOURNAL OF CONTROLLED RELEASE
- Cysteine-Functionalized Nanostructured Lipid Carriers for Oral Delivery of Docetaxel: A Permeability and Pharmacokinetic Study
- (2015) Guihua Fang et al. MOLECULAR PHARMACEUTICS
- Improved oral bioavailability of docetaxel by nanostructured lipid carriers: in vitro characteristics, in vivo evaluation and intestinal transport studies
- (2015) Guihua Fang et al. RSC Advances
- Co-encapsulation of borneol and paclitaxel by liprosomes improved anti-tumor effect in a xenografted glioma model
- (2015) Bo Tang et al. RSC Advances
- Lipid-albumin nanoassemblies co-loaded with borneol and paclitaxel for intracellular drug delivery to C6 glioma cells with P-gp inhibition and its tumor targeting
- (2015) Bo Tang et al. Asian Journal of Pharmaceutical Sciences
- Multi-drug resistance in cancer chemotherapeutics: Mechanisms and lab approaches
- (2014) Qiong Wu et al. CANCER LETTERS
- Novel hydrophobin-coated docetaxel nanoparticles for intravenous delivery: In vitro characteristics and in vivo performance
- (2014) Guihua Fang et al. EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES
- Liprosomes loading paclitaxel for brain-targeting delivery by intravenous administration: In vitro characterization and in vivo evaluation
- (2014) Bo Tang et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- RGD peptide conjugated liposomal drug delivery system for enhance therapeutic efficacy in treating bone metastasis from prostate cancer
- (2014) Fangfang Wang et al. JOURNAL OF CONTROLLED RELEASE
- Nanomedicine therapeutic approaches to overcome cancer drug resistance
- (2013) Janet L. Markman et al. ADVANCED DRUG DELIVERY REVIEWS
- Vitamin E reverses multidrug resistance in vitro and in vivo
- (2013) Jingling Tang et al. CANCER LETTERS
- Enhanced Tumor Targeting and Antitumor Efficacy via Hydroxycamptothecin-Encapsulated Folate-Modified N-Succinyl-N′-Octyl Chitosan Micelles
- (2013) Hongyan Zhu et al. JOURNAL OF PHARMACEUTICAL SCIENCES
- Three Decades of P-gp Inhibitors: Skimming Through Several Generations and Scaffolds
- (2012) A. Palmeira et al. CURRENT MEDICINAL CHEMISTRY
- Application of headspace solid phase microextraction for study of noncovalent interaction of borneol with human serum albumin
- (2009) Liang Hu et al. ACTA PHARMACOLOGICA SINICA
- Factors Affecting the Clearance and Biodistribution of Polymeric Nanoparticles
- (2008) Frank Alexis et al. MOLECULAR PHARMACEUTICS
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now